Literature DB >> 34100505

Juglone, a novel activator of ferroptosis, induces cell death in endometrial carcinoma Ishikawa cells.

Yuan-Yuan Zhang1, Zhi-Jing Ni2, Elnur Elam2, Fan Zhang1, Kiran Thakur1, Shaoyun Wang3, Jian-Guo Zhang1, Zhao-Jun Wei1.   

Abstract

Ferroptosis is a novel iron-dependent cell death pathway mainly caused by an abnormal redox state and associated with various diseases including cancer. Recently, much attention has been paid to natural compounds that are involved in its activation and inhibition. This is the first ever study to demonstrate the role of juglone isolated from Carya cathayensis green peel in inducing autophagy and inhibiting endometrial cancer (EC) cell migration. Subsequently, Fe2+ accumulation, lipid peroxidation, GSH depletion, the upregulation of HMOX1, and heme degradation to Fe2+ were reported. Juglone was involved in inducing autophagy and inhibiting cell migration and endoplasmic reticulum stress, which are the new hallmarks of cancer treatment. Collectively, our data indicate that juglone as a functional food ingredient induces the programmed cell death of EC cells by activating oxidative stress and suggest a novel therapeutic approach for the treatment and prevention of EC.

Entities:  

Year:  2021        PMID: 34100505     DOI: 10.1039/d1fo00790d

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

Review 1.  New Insights on Ferroptosis and Gynecological Malignancies.

Authors:  Ruiqi Fan; Yujun Sun; Mengxue Wang; Qian Wang; Aifang Jiang; Tingting Yang
Journal:  Front Mol Biosci       Date:  2022-06-14

2.  Amentoflavone promotes ferroptosis by regulating reactive oxygen species (ROS) /5'AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) to inhibit the malignant progression of endometrial carcinoma cells.

Authors:  Qi Sun; Peng Zhen; Dandan Li; Xiaochen Liu; Xinling Ding; Huihui Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.

Authors:  Sitian Wei; Zhicheng Yu; Rui Shi; Lanfen An; Qi Zhang; Qian Zhang; Tangansu Zhang; Jun Zhang; Hongbo Wang
Journal:  BMC Cancer       Date:  2022-08-12       Impact factor: 4.638

4.  Prediction of Prognosis in Patients With Endometrial Carcinoma and Immune Microenvironment Estimation Based on Ferroptosis-Related Genes.

Authors:  Shouze Liu; Qianqian Zhang; Wenhua Liu; Xianghua Huang
Journal:  Front Mol Biosci       Date:  2022-07-15

Review 5.  Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer.

Authors:  Jianfa Wu; Li Zhang; Suqin Wu; Zhou Liu
Journal:  Front Mol Biosci       Date:  2022-07-01

Review 6.  Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine.

Authors:  Xuan Wang; Peng Hua; Chengwei He; Meiwan Chen
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.